Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, $several factors including age, environment, disease state, and changes in lifestyle. "

VISIONARY LEADERS

Visionary leaders are the leading market players in terms of new developments such as product launches, innovative technologies, and the adoption of growth strategies. These players have a broad product offering that caters to most of the regions globally. Visionary leaders primarily focus on acquiring the leading market position through their strong financial capabilities and their well-established brand equity.

DYNAMIC DIFFERENTIATORS

Dynamic Differentiators are established players with very strong business strategies. However, they have a weaker product portfolio compared to the visionary leaders. They generally focus only on a specific type of technology related to the product.

INNOVATORS

Innovators in the competitive leadership mapping are vendors that have demonstrated substantial product innovations as compared to their competitors. The companies have focused on product portfolios. However, they do not have very strong growth strategies for their overall business, when compared with the visionary leaders.

EMERGING COMPANIES

Emerging companies have niche product and service offerings. Their business strategies are not as strong as that of the established vendors. The emerging vendors include the new entrants in the market, emerging in terms of product portfolio and geographic reach, and require time to gain significant traction in the market.

Epigenetics Products

Comparing 26 vendors in Epigenetics Products across 79 criteria.
All vendors(26)
Filters
Reset

24
5
26
4
10
5
10
2
11
22
13
19
17
18
15
13
15
16
10
15
23
18
21
23
17
Thermo Fisher Scientific offers a wide range of products like kits, reagents, assays, enzymes, and instruments for epigenetics. The company invested USD 755 million of its total revenue in 2016 on R&D activities to develop new and innovative products. The company’s products are used by pharmaceutical and biotechnology companies, and clinical, academic and government institutions. The company plans to adopt product development as a strategy to remain competitive in the market.
Read less Read more
Illumina is a global leader in providing sequencing and array-based solutions for genetic analysis. Illumina is a global leader in providing sequencing and array-based solutions for genetic analysis. The company offers its product portfolio to universities, research centers, government institutes, and pharmaceutical and biotechnology companies. The company continues to increase its investment in R&D activities. In the past two years, the company invested heavily to provide new and innovative products.
Read less Read more
Merck offers a range of epigenetics consumables like kits, enzymes, assays, and antibodies to various academic institutions and pharmaceutical companies. Merck offers a range of epigenetics consumables like kits, enzymes, assays, and antibodies to various academic institutions and pharmaceutical companies. The company offers high-quality products to a wide end-user base under the brand name Merck, with the only exceptions in Canada and the US where the brand name is MilliporeSigma – following the complete acquisition of Sigma-Aldrich. The company focuses on the development of innovative products to provide efficient solutions to customers.
Read less Read more
3.2
QIAGEN is a global leader in Sample to Insights solutions with a wide range of products used to extract, purify and stabilize DNA, RNA and protein from biological samples. QIAGEN is a global leader in Sample to Insights solutions with a wide range of products used to extract, purify and stabilize DNA, RNA and protein from biological samples. QIAGEN markets and sells its products in several countries to molecular diagnostics laboratories; academia; pharmaceutical and biotechnology companies; and government and private laboratories. The company invested USD 17.6 million of its total revenue in 2016 to develop new and innovative products.
Read less Read more
Bio-Rad offers its epigenetics products, such as kits, reagents, assays, PCR amplification, and software through its life science segment. The company offers its epigenetics products, such as kits, reagents, assays, PCR amplification, and software through its life science segment. The company consistently makes heavy investments to develop new products and applications. The company is known to offer its research-use products to academic institutes, pharmaceutical & biotechnological companies, government institutions, and CROs for their application in a range of research studies involving proteomics, genomics, biochemistry, and molecular biology.
Read less Read more